PubMed Health⌕ Search

Biomedical subjects

J Botella de Maglia

Publications and source records attributed to J Botella de Maglia.

15 recordsLinked to original sources
PubMed2005

[Changes in spirometric parameters and arterial oxygen saturation during a mountain ascent to over 3000 meters].

OBJECTIVE: To ascertain whether climbing a mountain over 3000 meters high produces any alterations in ventilation, whether such alterations are modified by acclimatization, and whether they correlate with changes in arterial oxygen saturation (SaO2) or the development of acute mountain sickness (AMS). SUBJECTS AND METHODS: The following parameters were measured in 8 unacclimatized mountaineers who climbed Aneto (3404 m) and spent 3 days at the summit: forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), airway response to inhaled terbutaline, SaO2, and the symptoms of AMS. RESULTS: At the summit, mean (SD) FEV1 declined by 12.3% (5.7%) and mean FVC by 7.6% (6.7%) while the ratio of FEV1 to FVC remained normal. The means for both parameters were higher on the following day. No airway response to bronchodilator treatment was observed. The restriction disappeared entirely on descent. At the peak, SaO2 increased progressively as the climbers became acclimatized. During the ascent, FEV1 correlated with SaO2 (r=0.79). One participant who suffered from AMS had a ratio of FEV1 to FVC less than 70% and the worst SaO2 during the 3 days on the summit. Obstruction preceded the AMS symptoms, did not respond to bronchodilator treatment, and disappeared when the climber descended. CONCLUSIONS: The mountaineers who climbed over 3000 meters presented restriction that correlated with hypoxemia. This restriction did not respond to bronchodilator treatment, improved with acclimatization, and disappeared on descent. One person with AMS presented obstruction that did not respond to terbutaline and disappeared on descent.

Adult↗
PubMed2003

[Triiodothyronine intoxication. A clinical and phamacokinetic study].

A woman, thyroidectomised because of a thyroid papillary carcinoma, interrupted temporarily her levothyroxine intake in order to be subjected to an extension study five weeks later. To minimise her symptoms for the first three weeks, a treatment was prescribed consisting of one 25 micro g-capsule of triiodothyronine every 8 hours. Nine days later she complained of abdominal pain, nausea, vomiting, fever of 40 degrees C and chest discomfort. A serum total triiodothyronine of 575.2 nmol/l was measured by chemoluminiscent immunoassay eleven hours after the intake of the latest capsule (normal level: 1.1-2.9 nmol/l). Along the following ten days the patient suffered from delirium, agitation, tachycardia, hypertension, constipation and later diarrhoea, but neither arrythmias nor axillary temperature over 38 degrees C. Fifty-nine measurements of the serum total triiodothyronine were performed in order to determine the kinetics of elimination of this drug. We estimate that the maximal serum concentration after the intake of the latest capsule could be 794.3 nmol/l, i.e. 397 times higher than the mean normal value. The elimination half-life was 24 hours 40 minutes. The charcoal haemoperfusion had no impact on the velocity of elimination. The concentration of triiodothyronine became normal 200 hours after the intake of the latest capsule, but the clinical manifestations still lasted three days more. The pharmacokinetic data suggest that this intoxication could be due to the intake of capsules containing 5 mg of triiodothyronine, i.e. a dose 200 times higher than that prescribed by her physician.

Absorption↗
PubMed2000

[Paraquat poisoning. A study of 29 cases and evaluation of the effectiveness of the "Caribbean scheme"].

BACKGROUND: To study clinical aspects of the oral paraquat intoxication and to assess the effectiveness of both the charcoal haemoperfusion and the so-called "Caribbean scheme" (cyclophosphamide, dexamethasone, furosemide and vitamins B and C) to reduce its mortality. PATIENTS AND METHOD: Retrospective study of 29 consecutive cases admitted to our intensive care unit in 17 years. RESULTS: a) Twenty five men and four women ingested 20% paraquat solution, either accidentally (4 subjects) or deliberately (25 subjects). The suicidal purpose was particularly strong among men aged 50-66 years. Most of patients had vomits and diarrhoea. All patients developed oral and pharyngeal caustic lesions. Hypokalaemia was detected on admission in 9 patients. Increased levels of serum aminotransferases, bilirubin, amylase or creatinkinase were detected in some patients. Twenty two patients developed acute renal failure and 18 patients respiratory failure. Twenty patients died (ten in the first 48 hours and ten between days 3 and 30); b) charcoal haemoperfusion was performed on 16 patients; 4 of the 16 treated patients survived, versus 5 of the 13 non treated (p = NS), and c) the "Caribbean scheme" was applied on 18 patients. All but one of the 11 subjects who ingested >= 45 ml (treated with the "Caribbean scheme" or not) died. Among those who ingested 45 ml, 8 of the 12 treated patients survived, versus none of the 6 non treated ones (p < 0.05). CONCLUSIONS: Charcoal haemoperfusion did not reduce mortality of paraquat. The "Caribbean scheme" was associated with a lesser mortality in the subjects who ingested 45 ml of 20% paraquat solution.

Acute Kidney Injury↗
PubMed1998

[High altitude retinal hemorrhages in the expeditions to 8,000 meter peaks. A study of 10 cases].

BACKGROUND: Retinal haemorrhages are common at high altitude. Their pathogenesis is unknown. It has been suggested that they are less frequent in sherpas, and that possible predisposing factors might be the abscence of previous high-altitude experience, the extent of the high-altitude hypoxic exposure, polycythemia (because of hyperviscosity), history of cough and Valsalva manoeuvres during the expedition, existence of severe forms of mountain sickness (high-altitude pulmonary oedema and high-altitude cerebral oedema) and use of antiinflammatory drugs. The aim of this study is to know the incidence of retinal haemorrhages in the expeditions to mountains higher than 8.000 m and their relationship to the previously referred possible predisposing factors. SUBJECTS AND METHODS: Funduscopy was performed on 17 healthy subjects taking part in expeditions to Cho-Oyu (8.201 m) and to Shisha Pangma (8.046 m) and on six of their Nepali coworkers. RESULTS: Retinal haemorrhages were found in 10 of the European (59%) and in none of the Nepali mountaineers (p = 0.019). Other 2 Spanish climbers had tortuosity and engorgment of the retinal veins. No statistical association was found between retinal haemorrhages and maximal altitude attained prior to the expedition, maximal altitude reached during the present expedition, number of nights spent at extreme altitude, weight loss as an expression of chronic exposure to hypoxia, haemoglobin, history of cough or Valsalva manoeuvres during the expedition, existence of severe forms of mountain sickness or use of drugs. CONCLUSIONS: These results do not allow us to state that the mentioned factors predispose to high-altitude retinal haemorrhages.

Adult↗
PubMed1998

[Prospective study of nosocomial infections in a medical ICU. A proposal for the generalized use of the National Nosocomial Infection Surveillance System rates].

OBJECTIVE: To know the more relevant nosocomial infection (NI) rates in our Intensive Care Unit (ICU), risk factors associated with NI and trends in the infective flora. METHODS: During a three-month period, the cumulative incidence, density of overall incidence and device associated infection rates were determined in a total of 308 patients admitted to the medical ICU, following the recommendations of the National Nosocomial Infection Surveillance System (NNIS) in the USA. RESULTS: The cumulative incidence was 8.4 infections per 100 admissions. The density of overall incidence was 12.9 nosocomial infections per 1,000 days of ICU stay. Device-associated infection rates were: 28.9 pneumonia per 1,000 mechanical ventilation days, 5.3 urinary tract infections per 1,000 days of catheter use and 0.4 bacteremia per 1,000 days of central venous catheter. Pneumonia was the more common NI, followed by urinary tract infection. Pseudomonas aeruginosa was the microorganism recovered most frequently. The most common used antibiotics were third generation cephalosporins, followed by quinolones and macrolides. CONCLUSIONS: The use of NNIS rates is advisable because its allows to know the impact of NI on our unit and to perform comparative studies with other units of similar characteristics.

APACHE↗
PubMed1998

[Severe and complicated malaria. Report of six cases].

Six patients with severe and complicated falciparum malaria (6.7 +/- 2.7 WHO criteria) were admitted to our Intensive Care Unit. All patients acquired the disease while travelling in tropical Africa without appropriate chemoprophylaxis. The clinical manifestations included hyperpyrexia (all patients), chills (4), sweating (2), asthenia (3), anorexia (2), headache (1), arthralgias (1), vomiting (4), diarrhoea or abdominal discomfort (3), jaundice (2) and disturbances of consciousness (4). All patients had anemia, thrombocytopenia, hyponatremia, hypoproteinemia, hypoalbuminemia, hypocalcemia and acute renal failure, in one case associated with anuria. A low grade parasitemia was observed in two patients and a high grade parasitemia (20%-58% of erythrocytes) in four. Exchange transfusion was performed only in high parasitemic patients and all of them survived. All patients were treated with quinine, a sulfonamide and pyrimethamine. Additionally, five patients received oxytetracycline, doxycycline or clindamycin. Three patients required hemodyalisis. Five patients had delirium, coma or seizures. All patients had at least one sign of hepatic impairment: liver enlargement, jaundice or increased bilirubin or aminotransferase levels. Two patients had spleen enlargement. Laboratory findings suggested disseminated intravascular coagulation in four patients. Four patients developed pulmonary changes and three of them required mechanical ventilation. A Swan-Ganz catheter was placed in four patients. In three of them (two with pulmonary edema) the pulmonary capillary wedge pressure was initially increased, which suggested a cardiogenic or hypervolemia mechanism, but soon returned to normal level. One patient with low grade parasitemia died because of adult respiratory distress syndrome after 18 days. In our series, the degree of parasitemia was not related to the severity of the disease.

Adult↗
PubMed1995

[Multiple organ failure in Plasmodium falciparum malaria].

A 44-year-old Spanish woman travelled in Kenya without doing correct malarial prophylaxis. Upon her return to Spain, she suffered from Plasmodium falciparum malaria. She was initially treated with chloroquine for three days, but her state worsened and she was admitted to our intensive care unit. On admission, parasitaemia was 22%. She had hyperpyrexia, obtundation, hypotension, tachycardia, tachypnoea, jaundice, digestive haemorrhage, petechiae in her soles, oliguria with elevation of serum uraemia and creatinine, anaemia, thrombocytopaenia, hypoproteinaemia, hyponatraemia, hypocalcaemia, metabolic acidosis and parameters of disseminated intravascular coagulation. She was given quinine, sulfadoxine-pyrimethamine and clindamycin. An exchange transfusion was performed, during which an acute pulmonary oedema appeared, initially with high pulmonary artery wedge pressure. She required mechanical ventilation for 16 days and haemodialysis for 11 days. She remained in coma and had seizures which required diazepam, phenitoin and thiopentone. She received a total amount of 22 units of packed erythrocytes, 55 of platelets and 15 of plasma. After the first week, she had nosocomial infection due to Escherichia coli, Staphylococcus and Pseudomonas aeruginosa and was treated with the corresponding antibiotics. She cured completely. This case report gives us the possibility of discussing on frequent problems in the prevention and treatment of malaria, and on the treatment of severe, life-threatening malaria in the setting of the intensive care unit.

Acute Disease↗
PubMed1993

[Transient motor aphasia at high altitude].

Three healthy mountaineers had episodes of transient motor aphasia at 5,547, 8,000 and 7,000 metres respectively. In the three cases the comprehension was preserved. Aphasia was neither accompanied nor followed by headache, motor disturbances or any other neurologic symptoms and signs. We suspect that transient motor aphasia is more frequent at high altitude than can be concluded from its low frequency of apparition in the medical literature. Among the pathogenic hypotheses, we consider the disfunction of language-related brain areas due to vascular obstruction by microthrombi of platelets and fibrin or to selective hypocapnic-mediated vasoconstriction, but a diffuse metabolic illness cannot be ruled out.

Adult↗
PubMed1991

[Plasmodium falciparum resistant to sulfadoxine/pyrimethamine in Senegal].

In 1983, the first African cases of malaria due to Plasmodium falciparum resistant to sulfadoxine/pyrimethamine, were described. Currently, this resistance is frequently found in Kenya and Tanzania. It has also been described in other African countries. A young Spanish woman contracted Plasmodium falciparum malaria in Senegal and was treated in our hospital with sulfadoxine/pyrimethamine. Fever and symptoms disappear within two days. The thick smears taken on the eighth and thirteenth days of treatment contained an abundance of gametocytes, but neither trophozoites nor schizonts. As the risk of transmission of malaria to the rest of the community was considered practically nil, no other treatment was administered. A month late, she was admitted to the hospital due to fever, shivering, fatigue, loss of appetite and hemolytic anaemia. The thick smear test again showed trophozoites of P. Falciparum. Thus, it proved to be a delayed grade I resistance to sulfadoxine/pyrimethamine, detected in far west Africa. An oral dose of mefloquine was administered as well as a red cell transfusion. Both fever and symptoms finally disappeared.

Adult↗